These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 25908255

  • 1. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
    Zhao YF, Zhang Q, Xi JY, Li YH, Ma CG, Xiao BG.
    J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y, Zhang Q, Xi J, Xiao B, Li Y, Ma C.
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [Abstract] [Full Text] [Related]

  • 3. L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.
    Luo L, Chen J, Su D, Chen M, Luo B, Pi R, Wang L, Shen W, Wang R.
    Neurochem Res; 2017 Feb; 42(2):615-624. PubMed ID: 28078613
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
    He Q, Li YH, Guo SS, Wang Y, Lin W, Zhang Q, Wang J, Ma CG, Xiao BG.
    Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
    [Abstract] [Full Text] [Related]

  • 5. Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.
    Li YH, Yu JW, Xi JY, Yu WB, Liu JC, Wang Q, Song LJ, Feng L, Yan YP, Zhang GX, Xiao BG, Ma CG.
    Mol Neurobiol; 2017 Sep; 54(7):5400-5413. PubMed ID: 27590141
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A, Kanthasamy A, Joseph J, Anantharam V, Srivastava P, Dranka BP, Kalyanaraman B, Kanthasamy AG.
    J Neuroinflammation; 2012 Oct 23; 9():241. PubMed ID: 23092448
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.
    Tönges L, Frank T, Tatenhorst L, Saal KA, Koch JC, Szego ÉM, Bähr M, Weishaupt JH, Lingor P.
    Brain; 2012 Nov 23; 135(Pt 11):3355-70. PubMed ID: 23087045
    [Abstract] [Full Text] [Related]

  • 8. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
    Jo MG, Ikram M, Jo MH, Yoo L, Chung KC, Nah SY, Hwang H, Rhim H, Kim MO.
    Mol Neurobiol; 2019 Jan 23; 56(1):39-55. PubMed ID: 29675576
    [Abstract] [Full Text] [Related]

  • 9. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
    Jiang L, Wu X, Wang S, Chen SH, Zhou H, Wilson B, Jin CY, Lu RB, Xie K, Wang Q, Hong JS.
    J Neuroinflammation; 2016 May 16; 13(1):110. PubMed ID: 27184631
    [Abstract] [Full Text] [Related]

  • 10. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU.
    J Neurochem; 2015 May 16; 133(4):590-7. PubMed ID: 25581060
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation.
    Moon M, Kim HG, Hwang L, Seo JH, Kim S, Hwang S, Kim S, Lee D, Chung H, Oh MS, Lee KT, Park S.
    Neurotox Res; 2009 May 16; 15(4):332-47. PubMed ID: 19384567
    [Abstract] [Full Text] [Related]

  • 12. Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice.
    Yao K, Zhao YF.
    Exp Gerontol; 2018 Oct 01; 111():86-93. PubMed ID: 30009921
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP.
    Lu C, Zhang J, Shi X, Miao S, Bi L, Zhang S, Yang Q, Zhou X, Zhang M, Xie Y, Miao Q, Wang S.
    Int J Biol Sci; 2014 Oct 01; 10(4):350-7. PubMed ID: 24719552
    [Abstract] [Full Text] [Related]

  • 14. The TLR4/NF-κB/NLRP3 and Nrf2/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease.
    Zhang C, Zhou J, Zhuo L, Zhang W, Lv L, Zhu L, Zhang J, Feng F, Liu W, Han L, Liao W.
    J Ethnopharmacol; 2024 Oct 28; 333():118391. PubMed ID: 38797377
    [Abstract] [Full Text] [Related]

  • 15. Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
    Yang C, Mo Y, Xu E, Wen H, Wei R, Li S, Zheng J, Li W, Le B, Chen Y, Pan H, Huang S, Wang S, Wang Q.
    Int Immunopharmacol; 2019 Oct 28; 75():105651. PubMed ID: 31401385
    [Abstract] [Full Text] [Related]

  • 16. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A, Lecca D, Mulas G, Wardas J, Simbula G, Spiga S, Carta AR.
    Neurobiol Dis; 2014 Nov 28; 71():280-91. PubMed ID: 25134730
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
    Lofrumento DD, Nicolardi G, Cianciulli A, De Nuccio F, La Pesa V, Carofiglio V, Dragone T, Calvello R, Panaro MA.
    Innate Immun; 2014 Apr 28; 20(3):249-60. PubMed ID: 23764428
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease.
    Liang Y, Chen C, Xia B, Wu W, Tang J, Chen Q, Tang L, Yang H, Zhang Z, Lu Y, Yang Y, Zhao Y.
    Biomed Res Int; 2019 Apr 28; 2019():4379639. PubMed ID: 30834264
    [Abstract] [Full Text] [Related]

  • 19. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment.
    Atiq A, Lee HJ, Khan A, Kang MH, Rehman IU, Ahmad R, Tahir M, Ali J, Choe K, Park JS, Kim MO.
    Int J Mol Sci; 2023 Jun 09; 24(12):. PubMed ID: 37373089
    [Abstract] [Full Text] [Related]

  • 20. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL, Wu YF, Yan F, Li CC, Dai Z, You QD, Jiang ZY, Di B.
    Free Radic Biol Med; 2019 Apr 09; 134():288-303. PubMed ID: 30615919
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.